COVID-19 vaccines effectiveness against symptomatic SARS-CoV-2 during Delta variant surge: a preliminary assessment from a case-control study in St. Petersburg, Russia

COVID-19 vaccines effectiveness against symptomatic SARS-CoV-2 during Delta variant surge: a preliminary assessment from a case-control study in St. Petersburg, Russia

Abstract Background Studies of mRNA and vector-based vaccines used in different countries report acceptable levels of effectiveness against SARS-CoV-2 infection caused by the Delta variants of SARS-CoV-2. No studies estimated vaccine effectiveness (VE) of Gam-COVID-Vac and other vaccines used in Rus...

Full description

Bibliographic Details
Main Authors: Anton Barchuk, Anna Bulina, Mikhail Cherkashin, Natalia Berezina, Tatyana Rakova, Darya Kuplevatskaya, Oksana Stanevich, Dmitriy Skougarevskiy, Artemiy Okhotin
Format: Article
Language:English
Published: BMC 2022-09-01
Series:BMC Public Health
Subjects:
Vaccine effectiveness
Case-control study
SARS-CoV-2
COVID-19
Online Access:https://doi.org/10.1186/s12889-022-14202-9

Internet

https://doi.org/10.1186/s12889-022-14202-9

Similar Items